Bethesda Healthcare Ltd
for the Year Ended 31 December 2024
Bethesda Healthcare Ltd
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Unaudited Financial Statements |
Bethesda Healthcare Ltd
Company Information
|
Director: |
C Hyman |
|
Registered office: |
|
|
Registered number: |
07830186 |
|
Accountants: |
|
Bethesda Healthcare Ltd
(Registration number: 07830186)
Balance Sheet as at 31 December 2024
|
Note |
31.12.24 |
31.12.23 |
|||
|
£ |
£ |
£ |
£ |
||
|
FIXED ASSETS |
|||||
|
Investments |
|
|
|||
|
CURRENT ASSETS |
|||||
|
Debtors |
|
|
|||
|
Cash at bank and in hand |
|
|
|||
|
|
|
||||
|
CREDITORS |
|||||
|
Creditors within 1yr |
22,356 |
21,219 |
|||
|
Net current assets |
|
|
|||
|
Net assets |
|
|
|||
|
CAPITAL AND RESERVES |
|||||
|
Called up share capital |
2 |
2 |
|||
|
Profit and loss account |
26,579 |
26,443 |
|||
|
Shareholders' funds |
26,581 |
26,445 |
|||
For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
Director's responsibilities:
|
• |
|
|
• |
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.
Approved and authorised by the
|
......................................... |
Bethesda Healthcare Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024
|
1. |
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
England
These financial statements were authorised for issue by the
|
2. |
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
The presentational currency is Pound Sterling (£).
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Tax
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
The Group inludes a number of companies, which are a part of a tax group for certain aspects of the tax legislation. One of these aspects relates to group relief whereby current tax liabilities can be offset by current tax losses arising in other companies within the same tax group. Payment for group relief is made equal to the tax benefit and amounts are included within the current tax disclosures.
Bethesda Healthcare Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024 (continued)
|
2 |
Accounting policies (continued) |
Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.
Dividends
|
3. |
Staff numbers |
The average number of persons employed by the company (including the director) during the year, was
|
4. |
Fixed Asset Investments |
|
Share in group undertakings |
|
|
Cost or valuation |
|
|
At 1 January 2024 |
|
|
Provision |
|
|
Carrying amount |
|
|
At 31 December 2024 |
|
|
At 31 December 2023 |
|
|
5. |
Debtors |
|
Note |
31.12.24 |
31.12.23 |
|
|
Amounts owed by group undertakings |
|
|
|
|
Other debtors |
|
|
|
|
|
|
Amount owned by group undertakings have no set interest or repayment terms.
Bethesda Healthcare Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024 (continued)
|
6. |
Creditors |
Creditors: amounts falling due within one year
|
Note |
31.12.24 |
31.12.23 |
|
|
Due within one year |
|||
|
Trade creditors |
|
|
|
|
Amounts owed by group undertakings |
|
|
|
|
Accruals and deferred income |
|
|
|
|
|
|
Amount owed to group undertakings have no set interest or repayment terms.
|
7. |
Related Party Disclosures |
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’, not to disclose related party transactions with wholly owned subsidiaries within the group.